ImStem Biotechnology
Farmington · Founded 2012
About ImStem Biotechnology
Imstem Biotechnology is a drug-research platform designed to focus on treatment of heart, vascular and blood system and autoimmune diseases. The company's drug-research platform produces cell therapeutic products from human embryonic stem cells to repair damaged tissues, enabling doctors to cure heart, vascular and blood system and autoimmune diseases
Company Facts
- Founded: 2012
- Legal name: ImStem Biotechnology Inc.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.1M
- Last round: Grant (Oct 2013)
- Website: imstem.com
- Phone: 860-281-7836
Social Profiles
Canonical: https://fsome.com/organization/imstem-biotechnology-8404863 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.